跳至主要内容
临床试验/NCT04801862
NCT04801862招募中不适用

Clinical, Microbiological and Genetic Factors Associated With Recurrence of Clostridioides Difficile Infection and Development of a Predictive Tool for Recurrence

Hospital Universitario de Valme15 个研究点 分布在 1 个国家目标入组 750 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
750
试验地点
15
主要终点
CDI recurrence

研究概览

简要总结

Aim: To investigate if host factors, such as composition and diversity of intestinal microbiota and/or genetic determinants, are associated with a higher risk of recurrence of Clostridioides difficile infection (CDI). To generate a predictive tool based on epidemiological, clinical, genetic and microbiologic variables aimed to identify patients at a higher risk of CDI recurrence in a context of optimized ICD management. Design: Multicenter prospective cohort study. Patients: Older than 18 years patients with CDI diagnosis, made by IDSA criteria, in the participant centers.

Follow-up: A stewarship program aimed to improve CDI management, including early detection of CDI recurrence, will be implemented in the participant centers. Blood samples for genetic testing and stool samples for intestinal microbiome studies will be collected.

Variables and data analysis: The primary outcome variable will be the emergence of CDI recurrence. Potential independent predictors of recurrence, including genetic and microbiological factors, will be assessed. A predictive tool based on independent predictors of recurrence will be built in a development subpopulation. The performance of the model will be assessed by ROC curves, and sensititvity, especificity, as well as negative and positive predictive values will be calculated, both in the development subpopulation and in a validation subset.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age older than 18 years
  • New episode of Clostridioides difficile infection, based on IDSA criteria.

排除标准

  • 未提供

结局指标

主要结局

CDI recurrence

时间窗: First 8 weeks after end of therapy

Clostridioides difficile recurrence

CDI reinfection

时间窗: Between 8 weeks after end of therapy and before 24 weeks

New episode of Clostridioides difficile infection

次要结局

  • Readmission due to CDI infection(During 24 weeks after the end of therapy)

研究者

发起方
Hospital Universitario de Valme
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicolás Merchante

Coordinator of the UCEIM-HUV Research Group

Hospital Universitario de Valme

研究点 (15)

Loading locations...

相似试验

Natural History of Clostridioides Difficile Infection | 临床试验